PRF Technologies (PRFX) Non Operating Income (2020 - 2024)
PRF Technologies' (PRFX) quarterly Non Operating Income came in at $33000.0 in Q2 2024, down 53.52% YoY from $71000.0 in Q3 2023, and down 44.07% on a QoQ basis from $59000.0 in Q1 2024.
PRF Technologies (PRFX) Non Operating Income (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of Non Operating Income data on file, last reported at $33000.0 in Q2 2024.
- Quarterly Non Operating Income fell 53.52% year-over-year to $33000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $161000.0 (down 39.25% YoY) and the FY2025 annual result came in at $108000.0, up 16.13% from the prior year.
- Non Operating Income slipped to $33000.0 in Q2 2024, from $59000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.4 million in Q3 2023 to a low of -$1.3 million in Q4 2023.
- A 5-year average of -$43388.9 and a median of $6000.0 in 2021 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 10776.92% in 2023, down 1432.32% in 2023.
- Tracing PRFX's Non Operating Income over 5 years: stood at $897000.0 in 2020, then sank by 98.44% to $14000.0 in 2021, then surged by 607.14% to $99000.0 in 2022, then tumbled by 1432.32% to -$1.3 million in 2023, then soared by 102.5% to $33000.0 in 2024.
- The last three Non Operating Income figures came in at $33000.0 (Q2 2024), $59000.0 (Q1 2024), and -$1.3 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | -1.32 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 71,000.00 |
| Mar 31, 2023 | 108,000.00 |
| Dec 31, 2022 | 99,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | 22,000.00 |
| Mar 31, 2022 | -22,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2021 | -3,000.00 |
| Jun 30, 2021 | -41,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | 897,000.00 |
| Sep 30, 2020 | -389,000.00 |
| Jun 30, 2020 | -519,000.00 |
| Mar 31, 2020 | -1.16 Mn |